drugset / Trial / NCT00171470

The Role of Tegaserod Therapy in the Management of Dyspeptic Symptoms in Female Patients on Proton Pump Inhibitors for the Treatment of Heartburn.

NCT00171470

Phase 3 Completed 60 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

Study to provide initial data to assess the safety and efficacy of tegaserod use in patients with dyspepsia that are being treated with proton pump inhibitors (PPI's) for heartburn.

Timeline

Start
2005-04
Primary completion
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Tegaserod Small molecule

Indications